Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 760694, 13 pages
http://dx.doi.org/10.1155/2014/760694
Research Article

Analysis of Oxidative Stress Enzymes and Structural and Functional Proteins on Human Aortic Tissue from Different Aortopathies

1Immunology Department, National Institute of Cardiology “Ignacio Chavez”, Juan Badiano 1, Sección XVI, Tlalpan, 14080 Mexico City, DF, Mexico
2Pathology Department, National Institute of Cardiology “Ignacio Chavez”, Juan Badiano 1, Sección XVI, Tlalpan, 14080 Mexico City, DF, Mexico
3Physiology Department, National Institute of Cardiology “Ignacio Chavez”, Juan Badiano 1, Sección XVI, Tlalpan, 14080 Mexico City, DF, Mexico
4Cardiovascular Surgery Department, National Institute of Cardiology “Ignacio Chavez”, Juan Badiano 1, Sección XVI, Tlalpan, 14080 Mexico City, DF, Mexico

Received 4 April 2014; Revised 28 May 2014; Accepted 28 May 2014; Published 1 July 2014

Academic Editor: Kota V. Ramana

Copyright © 2014 María Elena Soto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Xia, A.-L. Tsai, V. Berka, and J. L. Zweier, “Superoxide generation from endothelial nitric-oxide synthase: a Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process,” Journal of Biological Chemistry, vol. 273, no. 40, pp. 25804–25808, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. D. B. Sawyer, D. A. Siwik, L. Xiao, D. R. Pimentel, K. Singh, and W. S. Colucci, “Role of oxidative stress in myocardial hypertrophy and failure,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 4, pp. 379–388, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Rush, M. Nyara, J. V. Moxon, A. Trollope, B. Cullen, and J. Golledge, “Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm,” BMC Genomics, vol. 10, article 298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. H. H. C. Yang, C. van Breemen, and A. W. Y. Chung, “Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress,” Vascular Pharmacology, vol. 52, no. 1-2, pp. 37–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. O. Kane, N. Etienne-Selloum, S. V. F. Madeira et al., “Endothelium-derived contracting factors mediate the Ang II-induced endothelial dysfunction in the rat aorta: preventive effect of red wine polyphenols,” Pflugers Archiv European Journal of Physiology, vol. 459, no. 5, pp. 671–679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Serpillon, B. C. Floyd, R. S. Gupte et al., “Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 1, pp. H153–H162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Maiellaro-Rafferty, D. Weiss, G. Joseph, W. Wan, R. L. Gleason, and W. R. Taylor, “Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 301, no. 2, pp. H355–H362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Kaneko, T. Anzai, K. Horiuchi et al., “Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development,” Atherosclerosis, vol. 218, no. 2, pp. 470–478, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-O. Deguchi, H. Huang, P. Libby et al., “Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II,” Laboratory Investigation, vol. 89, no. 3, pp. 315–326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. J. Davies, “Oxidative stress: the paradox of aerobic life,” Biochemical Society symposium, vol. 61, pp. 1–31, 1995. View at Google Scholar · View at Scopus
  11. R. Bolli, M. O. Jeroudi, B. S. Patel et al., “Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: evidence that myocardial 'stunning' is a manifestation of reperfusion injury,” Circulation Research, vol. 65, no. 3, pp. 607–622, 1989. View at Google Scholar · View at Scopus
  12. J.-C. Charniot, D. Bonnefont-Rousselot, J.-P. Albertini et al., “Oxidative stress implication in a new ex-vivo cardiac concordant xenotransplantation model,” Free Radical Research, vol. 41, no. 8, pp. 911–918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. K. Griendling, D. Sorescu, and M. Ushio-Fukai, “NAD(P)H oxidase: role in cardiovascular biology and disease,” Circulation Research, vol. 86, no. 5, pp. 494–501, 2000. View at Google Scholar · View at Scopus
  14. K. K. Griendling, D. Sorescu, B. Lassègue, and M. Ushio-Fukai, “Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 10, pp. 2175–2183, 2000. View at Google Scholar · View at Scopus
  15. C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah, “NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure,” Cardiovascular Research, vol. 71, no. 2, pp. 208–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Downey, T. Miura, L. J. Eddy et al., “Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart,” Journal of Molecular and Cellular Cardiology, vol. 19, no. 11, pp. 1053–1060, 1987. View at Google Scholar · View at Scopus
  17. L. J. Eddy, J. R. Stewart, H. P. Jones, T. D. Engerson, J. M. McCord, and J. M. Downey, “Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 253, no. 3, pp. H709–H711, 1987. View at Google Scholar · View at Scopus
  18. K. M. Minhas, R. M. Saraiva, K. H. Schuleri et al., “Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy,” Circulation Research, vol. 98, no. 2, pp. 271–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Ide, H. Tsutsui, S. Kinugawa et al., “Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium,” Circulation Research, vol. 85, no. 4, pp. 357–363, 1999. View at Google Scholar · View at Scopus
  20. S. Umar and A. Van Der Laarse, “Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart,” Molecular and Cellular Biochemistry, vol. 333, no. 1-2, pp. 191–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Takimoto, H. C. Champion, M. Li et al., “Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1221–1231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. W. F. Saavedra, N. Paolocci, M. E. St. John et al., “Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart,” Circulation Research, vol. 90, no. 3, pp. 297–304, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Yue, Q. Qin, M. V. Cohen, J. M. Downey, and S. D. Critz, “The relative order of mKATP channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart,” Cardiovascular Research, vol. 55, no. 3, pp. 681–689, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. C. N. White, C.-C. Liu, A. Garcia et al., “Activation of cAMP-dependent signaling induces oxidative modification of the cardiac Na+-K+ pump and inhibits its activity,” Journal of Biological Chemistry, vol. 285, no. 18, pp. 13712–13720, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Q.-M. Zhao, T.-T. Feng, X. Zhao et al., “Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography,” Chinese Medical Journal, vol. 124, no. 6, pp. 911–917, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Filer, D. Nicholls, R. Corston, P. Carey, and P. Bacon, “Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage,” Journal of Rheumatology, vol. 28, no. 12, pp. 2752–2753, 2001. View at Google Scholar · View at Scopus
  27. V. Nayar, A. Santarsieri, and M. Belham, “Interrupted aorta in mosaic Turner syndrome,” Cardiology Journal, vol. 18, no. 5, pp. 568–569, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. K. Halushka, “Single gene disorders of the aortic wall,” Cardiovascular Pathology, vol. 21, no. 4, pp. 240–244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Gao, K. L. Siu, K. Chalupsky et al., “Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid,” Hypertension, vol. 59, no. 1, pp. 158–166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. K. H. Mortensen, B. E. Hjerrild, K. Stochholm et al., “Dilation of the ascending aorta in Turner syndrome—a prospective cardiovascular magnetic resonance study,” Journal of Cardiovascular Magnetic Resonance, vol. 13, no. 1, article 24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Doganay, E. Kocakoc, and Y. Sen, “Aortic aneurysm in a girl with Takayasu's arteritis,” New Zealand Medical Journal, vol. 123, no. 1326, pp. 124–125, 2010. View at Google Scholar · View at Scopus
  32. T. Hirase and K. Node, “Endothelial dysfunction as a cellular mechanism for vascular failure,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 3, pp. H499–H505, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Espinola-Zavaleta, M. E. Soto-López, E. Carreón-Torres et al., “Altered flow-mediated vasodilatation, low paraoxonase-1 activity, and abnormal high-density lipoprotein subclass distribution in Takayasu's arteritis,” Circulation Journal, vol. 73, no. 4, pp. 760–766, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. E. Ostberg, A. E. Donald, J. P. J. Halcox, C. Storry, C. McCarthy, and G. S. Conway, “Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 9, pp. 5161–5166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. H. T. Syyong, A. W. Y. Chung, H. H. C. Yang, and C. Van Breemen, “Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome,” British Journal of Pharmacology, vol. 158, no. 6, pp. 1597–1608, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Moinuddin, M. N. Inamdar, K. S. Kulkarni, and C. Kulkarni, “Modulation of hemodynamics, endogenous antioxidant enzymes, and pathophysiological changes by angiotensin-converting enzyme inhibitors in pressure-overload rats,” Hellenic Journal of Cardiology, vol. 52, no. 3, pp. 216–226, 2011. View at Google Scholar · View at Scopus
  37. N. Mahajan, V. Dhawan, S. Malik, and S. Jain, “Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease,” International Journal of Cardiology, vol. 145, no. 2, pp. 286–288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. E. F. Davidenkova, V. V. Grigor'eva, M. G. Shafran, D. K. Verlinskaia, and M. V. Prozorova, “Lipid peroxidation and the myeloperoxidase activity of neutrophilic leukocytes in shereshevskyǐ-Turner syndrome,” Byulleten Eksperimentalnoi Biologii i Meditsiny, vol. 94, no. 8, pp. 72–73, 1982. View at Google Scholar · View at Scopus
  39. H. Bentall and A. De Bono, “A technique for complete replacement of the ascending aorta,” Thorax, vol. 23, no. 4, pp. 338–339, 1968. View at Google Scholar · View at Scopus
  40. L. Faivre, G. Collod-Beroud, L. Adès et al., “The new Ghent criteria for Marfan syndrome: what do they change?” Clinical Genetics, vol. 81, no. 5, pp. 433–442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. W. P. Arend, B. A. Michel, D. A. Bloch et al., “The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis,” Arthritis and Rheumatism, vol. 33, no. 8, pp. 1129–1134, 1990. View at Google Scholar · View at Scopus
  42. A. Kleczkowska, E. Dmoch, E. Kubien, J. P. Fryns, and H. Van den Berghe, “Cytogenetic findings in a consecutive series of 478 patients with Turner syndrome. The Leuven experience 1965–1989,” Genetic Counseling, vol. 1, no. 3-4, pp. 227–233, 1990. View at Google Scholar · View at Scopus
  43. World Medical Association, “Declaration of Helsinki. Ethical principles for medical research involving human subjects,” Nursing Ethics, vol. 9, no. 1, pp. 105–109, 2002. View at Google Scholar
  44. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  45. I. Pérez-Torres, P. Roque, M. El Hafidi, E. Diaz-Diaz, and G. Baños, “Association of renal damage and oxidative stress in a rat model of metabolic syndrome. Influence of gender,” Free Radical Research, vol. 43, no. 8, pp. 761–771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Flohe and F. Otting, “Oxygen radicals in biological systems,” Methods Enzymology, vol. 105, pp. 501–600, 1984. View at Google Scholar
  47. E. M. Gregory and I. Fridovich, “Visualization of catalase on acrylamide gels,” Analytical Biochemistry, vol. 58, no. 1, pp. 57–62, 1974. View at Google Scholar · View at Scopus
  48. E. Beutler, “The relationship of red cell enzymes to red cell life-span,” Blood Cells, vol. 14, no. 1, pp. 69–75, 1988. View at Google Scholar · View at Scopus
  49. L. Flohé and W. A. Günzler, “Assays of glutathione peroxidase,” Methods Enzymology, vol. 105, no. 1, pp. 114–121, 1984. View at Google Scholar
  50. J. Belik, R. P. Jankov, J. Pan, M. Yi, C. R. Pace-Asciak, and A. K. Tanswell, “Effect of 8-isoprostaglandin F2α on the newborn rat pulmonary arterial muscle and endothelium,” Journal of Applied Physiology, vol. 95, no. 5, pp. 1979–1985, 2003. View at Google Scholar · View at Scopus
  51. V. Dhawan, N. Mahajan, and S. Jain, “Role of C-C chemokines in Takayasu's arteritis disease,” International Journal of Cardiology, vol. 112, no. 1, pp. 105–111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. S. J. Miller, W. C. Watson, K. A. Kerr et al., “Development of progressive aortic vasculopathy in a rat model of aging,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 5, pp. H2634–H2643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Rezzani, F. Bonomini, S. Tengattini, A. Fabiano, and R. Bianchi, “Atherosclerosis and oxidative stress,” Histology and Histopathology, vol. 23, no. 3, pp. 381–390, 2008. View at Google Scholar · View at Scopus
  54. S. K. Roy Chowdhury, G. V. Sangle, X. Xie, G. L. Stelmack, A. J. Halayko, and G. X. Shen, “Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 298, no. 1, pp. E89–E98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. F. M. Faraci and S. P. Didion, “Vascular protection: superoxide dismutase isoforms in the vessel wall,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 8, pp. 1367–1373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Buldanlioglu, S. Turkmen, H. B. Ayabakan et al., “Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease,” British Journal of Dermatology, vol. 153, no. 3, pp. 526–530, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. P. H. Chan, M. Kawase, K. Murakami et al., “Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion,” Journal of Neuroscience, vol. 18, no. 20, pp. 8292–8299, 1998. View at Google Scholar · View at Scopus
  58. E. D. van Deel, Z. Lu, X. Xu et al., “Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction,” Free Radical Biology and Medicine, vol. 44, no. 7, pp. 1305–1313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Lubrano, P. Di Cecco, and G. C. Zucchelli, “Role of superoxide dismutase in vascular inflammation and in coronary artery disease,” Clinical and Experimental Medicine, vol. 6, no. 2, pp. 84–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Mármol, J. Sánchez, D. López et al., “Loss of adaptation to oxidative stress as a mechanism for aortic damage in aging rats,” Journal of Physiology and Biochemistry, vol. 63, no. 3, pp. 239–247, 2007. View at Google Scholar · View at Scopus
  61. Y. Wei, A. T. Whaley-Connell, K. Chen et al., “NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat,” Hypertension, vol. 50, no. 2, pp. 384–391, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. S. P. Didion, M. J. Ryan, L. A. Didion, P. E. Fegan, C. D. Sigmund, and F. M. Faraci, “Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice,” Circulation Research, vol. 91, no. 10, pp. 938–944, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Kondo, A. G. Reaume, T.-T. Huang et al., “Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia,” Journal of Neuroscience, vol. 17, no. 11, pp. 4180–4189, 1997. View at Google Scholar · View at Scopus
  64. J. Xu, S. Wang, M. Zhang, Q. Wang, S. Asfa, and M.-H. Zou, “Tyrosine nitration of PA700 links proteasome activation to endothelial dysfunction in mouse models with cardiovascular risk factors,” PLoS ONE, vol. 7, no. 1, Article ID e29649, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Suzuki, H. Tatsumi, S. Satoh et al., “Manganese-superoxide dismutase in endothelial cells: localization and mechanism of induction,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 265, no. 4, pp. H1173–H1178, 1993. View at Google Scholar · View at Scopus
  66. L. A. Macmillan-Crow and D. L. Cruthirds, “Invited review: manganese superoxide dismutase in disease,” Free Radical Research, vol. 34, no. 4, pp. 325–336, 2001. View at Google Scholar · View at Scopus
  67. G. A.Visner, S. E. Chesrown, J. Monnier, U. S. Ryan, and H. S. Nick, “Regulation of manganese superoxide dismutase: IL-1 and TNF induction in pulmonary artery and microvascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 188, no. 1, pp. 453–462, 1992. View at Google Scholar · View at Scopus
  68. B. H. Youseff, E. D. Holbrook, K. A. Smolnycki, and C. A. Rappleye, “Extracellular superoxide dismutase protects Histoplasma yeast cells from host-derived oxidative stress,” PLoS Pathogens, vol. 8, no. 5, Article ID e1002713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Ülker, D. McMaster, P. P. McKeown, and U. Bayraktutan, “Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation,” Cardiovascular Research, vol. 59, no. 2, pp. 488–500, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. S. W. Ballinger, C. Patterson, C. A. Knight-Lozano et al., “Mitochondrial integrity and function in atherogenesis,” Circulation, vol. 106, no. 5, pp. 544–549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Zanetti, J. Sato, Z. S. Katusic, and T. O'Brien, “Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 280, no. 6, pp. H2516–H2523, 2001. View at Google Scholar · View at Scopus
  72. T. Nishikawa, D. Edelstein, X. L. Du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Rizki, C. L. Picard, C. Pereyra, and S. S. Lee, “Host cell factor 1 inhibits SKN-1 to modulate oxidative stress responses in Caenorhabditis elegans,” Aging Cell, vol. 11, no. 4, pp. 717–721, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Serratrice, A. Benyamine, V. Vidal et al., “Simultaneous occurrence of diffuse Takayasu's arteritis and severe disseminated tuberculosis,” Revue de Medecine Interne, vol. 29, no. 6, pp. 520–523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. G. S. Kerr, C. W. Hallahan, J. Giordano et al., “Takayasu arteritis,” Annals of Internal Medicine, vol. 120, no. 11, pp. 919–929, 1994. View at Google Scholar · View at Scopus
  76. A. G. Rose and C. C. Sinclair-Smith, “Takayasu's arteritis: a study of 16 autopsy cases,” Archives of Pathology and Laboratory Medicine, vol. 104, no. 5, pp. 231–237, 1980. View at Google Scholar · View at Scopus
  77. A. Duzova, Ö. Türkmen, A. Çinar, S. Çekirge, U. Saatci, and S. Ozen, “Takayasu's arteritis and tuberculosis: a case report,” Clinical Rheumatology, vol. 19, no. 6, pp. 486–489, 2000. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Golubović, I. Stanković, L. Ristić, V. Cosić, I. Dordević, and M. Radović, “Antioxidant enzymes and lipid peroxidation products in patients with pulmonary tuberculosis,” Medicinski Pregled, vol. 63, no. 7-8, pp. 450–453, 2010. View at Google Scholar · View at Scopus
  79. J.-N. Wang, N. Shi, and S.-Y. Chen, “Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells,” Free Radical Biology and Medicine, vol. 52, no. 1, pp. 173–181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. G. S. Dhaunsi, M. H. M. Yousif, S. Akhtar, M. C. Chappell, D. I. Diz, and I. F. Benter, “Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities,” European Journal of Pharmacology, vol. 638, no. 1–3, pp. 108–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. X. F. Zhou, J. Cui, A. L. Destefano et al., “Polymorphisms in the promoter region of catalase gene and essential hypertension,” Disease Markers, vol. 21, no. 1, pp. 3–7, 2005. View at Google Scholar · View at Scopus
  82. R. Polimanti, S. Piacentini, N. Lazzarin, M. A. Re, D. Manfellotto, and M. Fuciarelli, “Glutathione S-transferase variants as risk factor for essential hypertension in Italian patients,” Molecular and Cellular Biochemistry, vol. 357, no. 1-2, pp. 227–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Rybka, D. Kupczyk, K. Kȩdziora-Kornatowska et al., “Glutathione-related antioxidant defense system in elderly patients treated for hypertension,” Cardiovascular Toxicology, vol. 11, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. B. L. Gupta, A. Preet, and N. Z. Baquer, “Protective effects of sodium orthovanadate in diabetic reticulocytes and ageing red blood cells of Wistar rats,” Journal of Biosciences, vol. 29, no. 1, pp. 73–79, 2004. View at Google Scholar · View at Scopus
  85. H. Nandeesha, V. Sathiyapriya, Z. Bobby, P. Pavithran, A. Agrawal, and N. Selvaraj, “Altered oxidant-antioxidant status in non-obese men with moderate essential hypertension,” Indian Journal of Medical Sciences, vol. 61, no. 6, pp. 326–331, 2007. View at Google Scholar · View at Scopus
  86. Y. Chen, M. Zhou, and H. Kong, “Lipoperoxidative damage in experimental rabbits with atherosclerosis,” Chinese Medical Journal, vol. 106, no. 2, pp. 110–114, 1993. View at Google Scholar · View at Scopus
  87. V. Z. Lankin, “Lipid peroxides and atherosclerosis. Hypothesis: the role of cholesterol and free radical lipid peroxidation in alteration of the cell membrane properties in hypercholesterolemia and atherosclerosis,” Kardiologiya, vol. 20, no. 8, pp. 42–48, 1980. View at Google Scholar · View at Scopus
  88. A. Ahmad, U. Singhal, M. M. Hossain, N. Islam, and I. Rizvi, “The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension,” Journal of Clinical and Diagnostic Research, vol. 7, no. 6, pp. 987–990, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. H. H. C. Yang, C. van Breemen, and A. W. Y. Chung, “Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress,” Vascular Pharmacology, vol. 52, no. 1-2, pp. 37–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. A. W. Y. Chung, K. Au Yeung, S. F. Cortes et al., “Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome,” British Journal of Pharmacology, vol. 150, no. 8, pp. 1075–1083, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. X. Jiang, F. Yang, H. Tan et al., “Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2515–2521, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. S. D. Chauhan, G. Seggara, P. A. Vo, R. J. Macallister, A. J. Hobbs, and A. Ahluwalia, “Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice,” The FASEB Journal, vol. 17, no. 6, pp. 773–775, 2003. View at Google Scholar · View at Scopus
  93. W. Xiong, J. Mactaggart, R. Knispel et al., “Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model,” Atherosclerosis, vol. 202, no. 1, pp. 128–134, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. J. E. Barbato, B. S. Zuckerbraun, M. Overhaus, K. G. Raman, and E. Tzeng, “Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 1, pp. H228–H236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. A. S. Levy, J. C. S. Chung, J. T. Kroetsch, and J. W. E. Rush, “Nitric oxide and coronary vascular endothelium adaptations in hypertension,” Vascular Health and Risk Management, vol. 5, pp. 1075–1087, 2009. View at Google Scholar · View at Scopus
  96. M. Y. Lee and K. K. Griendling, “Redox signaling, vascular function, and hypertension,” Antioxidants and Redox Signaling, vol. 10, no. 6, pp. 1045–1059, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Li and N. K. Fukagawa, “Age-related changes in redox signaling and VSMC function,” Antioxidants and Redox Signaling, vol. 12, no. 5, pp. 641–655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Piechota-Polanczyk, A. Goraca, S. Demyanets et al., “Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB,” European Journal of Vascular and Endovascular Surgery, vol. 44, no. 2, pp. 133–137, 2012. View at Publisher · View at Google Scholar · View at Scopus